ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:


SEARCH JOBS


Industry
Biotechnology


Collaborations

Affinimark Technologies Inc. 





 Company News
Biocryst Pharmaceuticals (BCRX) Announces Nature Publication Demonstrating Efficacy Of BCX4430 In A Non-Human Primate Model Of Filovirus Infection 3/3/2014 8:58:12 AM    More...
Biocryst Pharmaceuticals (BCRX) Presents BCX4161 Phase 1 Trial And Kallikrein Inhibition Assay Results 3/3/2014 8:56:25 AM    More...
Biocryst Pharmaceuticals (BCRX) Reports Fourth Quarter And Full Year 2013 Financial Results 2/26/2014 9:13:21 AM    More...
Biocryst Pharmaceuticals (BCRX) Announces Peramivir NDA Acceptance By The FDA 2/25/2014 9:00:36 AM    More...
Biocryst Pharmaceuticals (BCRX) To Present At Three Upcoming Investor Conferences 2/20/2014 8:57:15 AM    More...
Biocryst Pharmaceuticals (BCRX) to Announce Fourth Quarter And 2013 Financial Results February 26 2/12/2014 9:26:09 AM    More...
Biocryst Pharmaceuticals (BCRX) To Present At J.P. Morgan Healthcare Conference 1/3/2014 9:47:35 AM    More...
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Marburg Virus Disease 12/30/2013 8:30:42 AM    More...
Biocryst Pharmaceuticals (BCRX) Files For Government-Funded Flu Treatment 12/20/2013 8:15:22 AM    More...
Biocryst Pharmaceuticals (BCRX) Advances Second Generation Oral Plasma Kallikrein Inhibitors For Hereditary Angioedema Into Preclinical Development 12/18/2013 9:39:23 AM    More...
12345678910...